Aptevo Therapeutics Inc. Proceeds from (Repayments of) Restricted Cash, Financing Activities
Aptevo Therapeutics Inc. (APVO) reported Proceeds from (Repayments of) Restricted Cash, Financing Activities of -$10.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities · last filed 2018-03-13
- Aptevo Therapeutics Inc. proceeds from (repayments of) restricted cash, financing activities for the quarter ending 2017-12-31 was $0.00.
- Aptevo Therapeutics Inc. proceeds from (repayments of) restricted cash, financing activities for the quarter ending 2016-09-30 was $0.00.
- Aptevo Therapeutics Inc. proceeds from (repayments of) restricted cash, financing activities for fiscal 2017 was -$10.00M.
| Period end | Proceeds from (Repayments of) Restricted Cash, Financing Activities 3 month | Proceeds from (Repayments of) Restricted Cash, Financing Activities 6 month | Proceeds from (Repayments of) Restricted Cash, Financing Activities 9 month | Proceeds from (Repayments of) Restricted Cash, Financing Activities 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$10.00M 10-K · filed 2018-03-13 | ||
| 2017-09-30 | -$10.00M 10-Q · filed 2017-11-13 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$400.00K 10-Q · filed 2017-11-13 | ||
| 2016-06-30 | -$400.00K 10-Q · filed 2017-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |